Exhibit 10.38 GENERAL RELEASE AND SEPARATION AGREEMENT This General Release and Separation Agreement (hereafter "Agreement") is entered into as of this 10th day of October, 2002, (the "Effective Date") between Joseph M. Limber (the "Executive"), and...General Release and Separation Agreement • November 14th, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec
Exhibit 10.39 ACLARA BIOSCIENCES, INC. 1288 Pear Avenue, Mountain View, CA 94043 October 10, 2002 Joseph M. Limber 1515 Arriba Court Los Altos, CA 94024 Re: Change in Control Agreement Dear Mr. Limber: In connection with General Release and Separation...Aclara Biosciences Inc • November 14th, 2002 • Measuring & controlling devices, nec • California
Exhibit 10.36 October 15, 2002 Joseph M. Limber ACLARA BioSciences, Inc. 1288 Pear Avenue Mountain View, CA 94043 Re: InvaderCreator(R) Access Prior to Implementation of Updates Under the InvaderCreator(R) Access Agreement Dear Joe: Concurrent with...Aclara Biosciences Inc • November 14th, 2002 • Measuring & controlling devices, nec
Concurrent with entering into this letter agreement ("Letter"), ACLARA BioSciences, Inc., a Delaware corporation, with its place of business 1288 Pear Avenue, Mountain View, CA 94043 ("ACLA") and Third Wave Technologies, Inc., a Delaware corporation, with its place of business at 502 S. Rosa Road, Madison, Wisconsin 53719 ("TWT") are entering into a License Agreement, a Supply Agreement, and an InvaderCreator(R) Access Agreement (the "Concurrent Agreements") which collectively involve, among other things, certain licenses between the parties, the supply of Cleavase(R) enzyme by TWT to ACLA, and access by ACLA to TWT's InvaderCreator(R) software. Terms used in this Letter with an initial capital letter which are defined in the Concurrent Agreements shall have the meaning given to such terms in the Concurrent Agreements.
BACKGROUNDInvadercreator Access Agreement • November 14th, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec • California
Exhibit 10.37 Termination Agreement This Termination Agreement ("Agreement") is effective as of October 10, 2002 ("Effective Date"), by and between Roche Diagnostics Corporation, having its principal office at 9115 Hague Road, Indianapolis, Indiana...Termination Agreement • November 14th, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec
RecitalsSupply Agreement • November 14th, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec • California
RecitalsLicense Agreement • November 14th, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec • California
Exhibit 10.35 October 15, 2002 Joseph M. Limber ACLARA BioSciences, Inc. 1288 Pear Avenue Mountain View, CA 94043 Re: Transition Manufacturing Plan Dear Joe, Concurrent with entering into this letter agreement ("Letter"), ACLARA BioSciences, Inc., a...Aclara Biosciences Inc • November 14th, 2002 • Measuring & controlling devices, nec
